Home > Training > Videos and Webinars > Webinars

Webinars

The webinars below cover a range of topics important to NCSACW’s stakeholders. Click on the links below to view the archived versions of these webinars and to access resources including slides and handouts.

Highlighted Resource
- Supporting Your Collaborative When Planning for Safe Care for Infants with Prenatal Substance Exposure – Live Discussion Webinar
  This live webinar hosted by the National Center on Substance Abuse and Child Welfare (NCSACW) alongside representatives from child welfare and healthcare from several states discusses shared experiences and knowledge for serving pregnant and parenting women with opioid and other substance use disorders. This webinar will provide an overview of treatment needs of pregnant women with substance use disorders, and the elements of family-centered treatment, the effects of exposure to infants and treatment needs of infants with neonatal abstinence syndrome and infants in general, the key role collaboration plays to support parent treatment and recovery and infant safety and well-being, Plans of Safe Care, and challenges experienced by partnerships in many different states.
  
  Presenter(s):
  - - Jean Blankenship
      Child Welfare Program Specialist; Office on Child Abuse and Neglect, Children’s Bureau, ACYF, ACF, HHS
    - Jill Gresham
      Senior Associate; National Center on Substance Abuse and Child Welfare
    - Trenee Parker
      Director; Division of Family Services within the Department of Services for Children, Youth and Their Families; Delaware
    - Jen Donahue
      Child Abuse Investigation Coordinator; Office of the Child Advocate; Delaware
    - Monika Taylor
      Director Chemical Dependence; Crouse Health; New York
    - Susan Morris
      Substance Exposed Newborn Specialist; Child Protection Services Unit; Colorado
  Date: November 13, 2019
  Watch Video Supporting Your Collaborative When Planning for Safe Care for Infants with Prenatal Substance Exposure – Live Discussion Webinar

Expand All | Collapse All

Supporting Families in Child Welfare Affected by Opioid and Other Substance Use Disorders
- Resources to Support Families in Child Welfare Affected by Opioid and Other Substance Use Disorders
  This pre-recorded webinar features a variety of technical assistance resources including publications, webinars, and tools that communities can use to better serve families in child welfare affected by opioid and other substance use disorders. The intended audience for the webinar includes Policymakers, Community-Service Providers, Public Health Professionals, Healthcare Providers, Child Welfare Professionals, and Substance Use Disorder Treatment Providers.
  
  Presenter(s):
  - - Katie Ryan
    - Jill Gresham
  Date: September 10, 2018
  Watch Video Support Families in Child Welfare Affected by Opioid and Other Substance Use Disorders
- Supporting Families in Child Welfare Affected by Opioid and Other Substance Use Disorders
  This webinar will address how the opioid epidemic is affecting families, particularly pregnant women with opioid use disorders and their infants, and strategies to support them. Many systems are involved in decisions related to the treatment, care, and supervision of pregnant women with opioid use disorders. The systems are governed by a combination of federal regulations, state legislation, ethics, and system-specific guidelines. At times, this mixture of regulations and guidelines can result in conflicting recommendations regarding medical care, substance use treatment, and child safety. Systems must establish mechanisms for working together to develop a family-centered and coordinated approach. Strategies for strengthening collaboration will be discussed in this webinar.
  
  Presenter(s):
  - - Nancy K. Young, PhD
    - Sharon Amatetti. M.P.H.
    - Elaine Stedt, MSW
  Date: September 6, 2016
  Watch Video Supporting Families in Child Welfare Affected by Opioid and Other Substance Use Disorders
- Introduction to the Child Welfare Training Toolkit
  This webinar discusses the newly updated Child Welfare Training Toolkit. The toolkit is a training package developed to educate child welfare workers about substance use and co-occurring issues among families involved in the child welfare system. The training is intended to provide foundational knowledge to help child welfare workers understand substance use disorders and other co-occurring issues; identify when substance use is a factor in a child welfare case; learn strategies for engaging parents and families in services; understand potential effects for the parents, children, and caregivers; and learn the importance of collaboration within a system of care. The webinar provides an overview of the topics in the toolkit and strategies for adapting the content for use in your organization or agency. The content also includes a review of the range of training materials, which were developed to be easily adapted to meet the needs of child welfare trainers as a component of training systems, in-person workshops, or training sessions.
  
  Presenter(s):
  - - Jean Blankenship, MSW
      Child Welfare Program Specialist, Office on Child Abuse and Neglect, Children’s Bureau, ACYF, ACF, HHS
    - Kimberly Bishop Stevens, LCSW
      Sr. Program Associate, National Center on Substance Abuse and Child Welfare
    - Sarah O’ Rourke, MSW, MSPH
      Program Associate, National Center on Substance Abuse and Child Welfare
  Date: September 5, 2019
  Watch Video Introduction to the Child Welfare Training Toolkit
Infants with Prenatal Substance Exposure
- Supporting Your Collaborative When Planning for Safe Care for Infants with Prenatal Substance Exposure – Live Discussion Webinar
  This live webinar hosted by the National Center on Substance Abuse and Child Welfare (NCSACW) alongside representatives from child welfare and healthcare from several states discusses shared experiences and knowledge for serving pregnant and parenting women with opioid and other substance use disorders. This webinar will provide an overview of treatment needs of pregnant women with substance use disorders, and the elements of family-centered treatment, the effects of exposure to infants and treatment needs of infants with neonatal abstinence syndrome and infants in general, the key role collaboration plays to support parent treatment and recovery and infant safety and well-being, Plans of Safe Care, and challenges experienced by partnerships in many different states.
  
  Presenter(s):
  - - Jean Blankenship
      Child Welfare Program Specialist; Office on Child Abuse and Neglect, Children’s Bureau, ACYF, ACF, HHS
    - Jill Gresham
      Senior Associate; National Center on Substance Abuse and Child Welfare
    - Trenee Parker
      Director; Division of Family Services within the Department of Services for Children, Youth and Their Families; Delaware
    - Jen Donahue
      Child Abuse Investigation Coordinator; Office of the Child Advocate; Delaware
    - Monika Taylor
      Director Chemical Dependence; Crouse Health; New York
    - Susan Morris
      Substance Exposed Newborn Specialist; Child Protection Services Unit; Colorado
  Date: November 13, 2019
  Watch Video Supporting Your Collaborative When Planning for Safe Care for Infants with Prenatal Substance Exposure – Live Discussion Webinar
- Addressing Infants With Prenatal Substance Exposure: New York’s Implementation Strategies
  From September 2016 to March 2019, New York received in-depth technical assistance from the National Center on Substance Abuse and Child Welfare to help address the needs of pregnant women with opioid use disorder and other substance use disorders, their infants affected by prenatal substance exposure, and their families and caregivers. State leaders discuss their collaborative efforts and the strategies they are implementing to improve outcomes for this population of women and their families. Speakers: New York State Office of Alcoholism and Substance Abuse Services; New York State Department of Health; American College of Obstetricians and Gynecologists, District II.
  
  Presenter(s):
  - - Ken DeCerchio
    - Kristen Lawless
    - Kelly Gilchrist
    - Maria Morris-Groves
  Date: July 25, 2019
  Watch Video Addressing Infants With Prenatal Substance Exposure: New York’s Implementation Strategies
- Plans of Safe Care—What your Multidisciplinary Team Needs to Know
  In 2016, Section 503 of the Comprehensive Addiction and Recovery Act (CARA) modified sections of the Child Abuse Prevention and Treatment Act (CAPTA) related to infants with prenatal substance exposure and Plans of Safe Care. The Administration for Children and Families (ACF) has provided related guidance in two Program Instructions (PI 17-02 and PI 17-05) and one Information Memorandum (IM 16-05). Key elements of the ACF related guidance include where states have flexibility; confirms that “the development of a plan of safe care is required whether or not the circumstances constitute child maltreatment under state law;” clarifies that CAPTA does not specifically define a ‘plan of safe care,’ encourages collaborative planning and implementation of services.
  
  This webinar provides multidisciplinary teams with a shared understanding of the challenges facing infants and families affected by substance use disorders (SUD), identifies how diverse partners can contribute to a collaboration that supports the complex needs of these families and highlights resources that teams can use to support implementation of a collaborative approach to Plans of Safe Care for pregnant and parenting women with SUD, infants with prenatal substance exposure and their families.
  
  Presenter(s):
  - - Katie Ryan
  Date: May 9, 2019
  Watch Video Plans of Safe Care—What your Multidisciplinary Team Needs to Know
- Infants with Prenatal Substance Exposure: Yale New Haven Children's Hospital's Approach
  This webinar provides an overview the Yale New Haven Children’s Hospital initiative to improve the quality of care of infants with Neonatal Abstinence Syndrome. Dr. Matthew Grossman highlights research findings, including the methods and results of the hospital study published in Pediatrics. The interventions include non-pharmacologic therapies and a simplified approach to assessment for infants exposed to methadone in utero.
  
  Presenter(s):
  - - Matthew Grossman, MD
  Watch Video Infants with Prenatal Substance Exposure: Yale New Haven Children's Hospital's Approach
- Partnering to Support Families Affected by Opioid and Other Substance Use Disorders
  This webinar for the Regional Offices of the Substance Abuse and Mental Health Services Administration (SAMHSA); Administration on Children Youth and Families, Children’s Bureau (ACYF, CB); Health Resources & Services Administration, Maternal Child Health Bureau (HRSA, MCHB); and, the Administration for Children and Families (ACF), Office of Regional Operations, includes discussion about collaborative practice to enhance states’ capacity to support families affected by opioid and other substance use disorders. It also discusses support implementation of the prenatal substance exposure sections of the Child Abuse and Prevention Treatment Act (CAPTA). The webinar explains changes to the CAPTA statutes from the Comprehensive Addiction and Recovery Act (CARA) of 2016 and highlights local initiatives that are implementing the statutes.
  
  Presenter(s):
  - - Nancy K. Young, PhD
    - Elaine Stedt, MSW
  Watch Video Partnering to Support Families Affected by Opioid and Other Substance Use Disorders
- A Framework for Intervention for Infants with Prenatal Exposure and Their Families
  The Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment and the Administration on Children, Youth and Families, Children’s Bureau, Office on Child Abuse and Neglect, in partnership with the National Center on Substance Abuse and Child Welfare present a webinar to addresses practice and policy issues for infants with prenatal exposure and their families. The webinar introduces the Five Point Framework, which identifies points of intervention for comprehensive reform to prevent prenatal exposure and respond to the needs of pregnant women, mothers, their families and infants. The five points of intervention include pre-pregnancy, prenatal, identification at birth, post-partum, and infancy and beyond.
  
  Presenter(s):
  - - Nancy K. Young, PhD
  Date: January 10, 2017
  Watch Video A Framework for Intervention for Infants with Prenatal Exposure and Their Families
Medication-Assisted Treatment and Neonatal Abstinence Syndrome
- Part 1: Collaborative Approaches to Treating Pregnant Women with Opioid Use Disorders
  The first webinar in the series presents an overview and introduction to the newly released SAMHSA publication A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorders: Practice and Policy Considerations for Child Welfare, Collaborating Medical and Service Providers. The publication supports the efforts of states, tribes and local communities in addressing the needs of pregnant women with opioid use disorders, their infants and families.
  
  Presenter(s):
  - - Sharon Amatetti, MPA
    - Nancy K. Young, PhD
  Date: September 19, 2016
  Watch Video Part 1: Collaborative Approaches to Treating Pregnant Women with Opioid Use Disorders
- Part 2: Partnering to Treat Pregnant Women with Opioid Disorders: Lessons Learned from a Six Site Initiative
  The second webinar in the series, Partnering to Treat Pregnant Women with Opioid Use Disorders: Lessons Learned from a Six Site Initiative will provide an overview and share lessons from the SAMHSA-funded initiative, Substance Exposed Infants In-Depth Technical Assistance program. The webinar will feature key findings learned in Connecticut, Kentucky, Minnesota, New Jersey, Virginia and West Virginia.
  
  Presenter(s):
  - - Jean Blankenship, MSW
    - Linda Carpenter, MEd
    - Jill Gresham, MA
    - Kari Earle, MEd
  Date: September 28, 2016
  Watch Video Part 2: Partnering to Treat Pregnant Women with Opioid Disorders: Lessons Learned from a Six Site Initiative
- Early Identification and Treatment of Prenatally Exposed Infants
  In this webinar, attendees participated in a discussion on early identification of prenatally exposed infants at birth, definition of substance exposed infants across systems, and pharmacological and non-pharmacological treatment of infants with NAS. Attendees for this webinar included medical partners, specifically pediatricians, neonatologists, and others in the medical community who work closely with substance exposed infants at birth. A portion of time is dedicated for Q&A with Dr. Burke and the SEI-IDTA sites. Dr. Sharon Burke, M.D. is the Clinical Director of the Infant Toddler Rehabilitation Program at PSE&G Children’s Specialized Hospital in New Brunswick, New Jersey where she joined in 1993. She is also clinical instructor in Pediatrics and Neonatology at Rutgers University Hospital and RWJMC. She did a pediatric internship and residency at NBIMC and Neonatal-Perinatal Fellowship at SPMC. From 1989-1993, Dr. Burke was the Clinical Director of the Neonatal Intensive Care Unit at University Hospital, Newark, NJ Dr. Burke graduated from Ross University School of Medicine in 1983. She has won several awards and honors for her work.
  
  Presenter(s):
  - - Sharon Burke, MD
    - Malia Beckwith, MD
    - David Babitsky, MBA
  Date: September 3, 2013
  Watch Video Early Identification and Treatment of Prenatally Exposed Infants
- Opioid Use in Pregnancy: A Community's Approach, The Children and Recovering Mothers (CHARM) Collaborative
  Professionals from the child welfare, substance abuse treatment, dependency court, and medical fields have increasingly indicated that there are a growing number of child abuse and neglect investigations and cases involving parents who abuse opioids (e.g. heroin and prescription pain medications). Further complicating the issue is a misunderstanding of the use, efficacy, and implications for child safety of medication-assisted treatment to treat opioid dependency. This webinar features the Children and Recovering Mothers (CHARM) collaborative based in Burlington, VT. CHARM is a multidisciplinary group of agencies serving pregnant women with opioid dependence, their infants and families. Discussion centers on services provided and collaborative practice elements across systems at multiple points of intervention – prenatal, birth, and postpartum.
  
  Presenter(s):
  - - Nancy K. Young, PhD
    - Sally Borden, MEd
    - Karen Shea, MSW
  Date: September 23, 2014
  Watch Video Opioid Use in Pregnancy: A Community's Approach, The Children and Recovering Mothers (CHARM) Collaborative
- Opioid Use, Dependency, and Treatment in Pregnancy
  The Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Substance Abuse Treatment (CSAT) is pleased to present this Opioid Use Disorders and Treatment in Pregnancy webinar. The webinar will feature three national experts on the issue who will discuss how opioid use disorders are treated in pregnancy, its impact on infants and innovative strategies in working families. Hendrée Jones, PhD, Professor, Department of Obstetrics and Gynecology, School of Medicine, University of North Carolina (UNC), Chapel Hill and Executive Director, Horizons, co-author of the MOTHERS study. Dr. Jones will discuss the treatment of opioid use disorders during pregnancy and her work with women at UNC Horizons. Horizons is a program of the Department of Obstetrics and Gynecology at the UNC, Chapel Hill. The program provides substance abuse treatment for pregnant and parenting women and their children and works collaboratively with multiple service providers to provide a range of services. Carl Seashore, MD, Medical Director of the Newborn Nursery at UNC Chapel Hill, North Carolina Women's Hospital - Dr. Seashore will discuss the impact of prenatal exposure to opioids and share his experience in working with exposed infants in the Newborn period and with the Horizons program. Anne Johnston, MD, Associate Professor of Pediatrics, University of Vermont College of Medicine, Burlington, VT and Medical Director, Neonatal Medical Follow-Up Program, the University of Vermont Children's Hospital, Burlington, VT. Dr. Johnston also serves as the attending neonatologist at the University of Vermont Children's Hospital where she is a member of the CHARM collaborative, a group that provides care to infants prenatally exposed to opioids and their mothers. Dr. Johnston will highlight the features and services available to families through the CHARM collaborative following hospital discharge.
  
  Presenter(s):
  - - Anne Johnston, MD
    - Hendrée E. Jones, PhD
    - Carl Seashore, MD
  Date: May 13, 2015
  Watch Video Opioid Use, Dependency, and Treatment in Pregnancy
- Medication-Assisted Treatment (MAT) Series, Part I of II: Understanding MAT for Families Affected by Substance Use Disorders
  The convergence of various factors highlight the need to understand the efficacy, use and implications of medication-assisted treatment (MAT) for families receiving child welfare services. Individuals may be undergoing MAT for a variety of issues –mental health disorders, pain management and substance use. MAT for mental health issues can include use of psychotropic medications. MAT can be used to assist in pain management for both short and long-term conditions. Medical marijuana legislation further compounds the issue as individuals can be prescribed marijuana for pain management and other disorders. The advent of new medications highlight the need to understand MAT for substance use disorders.
  
  In the first of this two-part series, presenters will provide an overview of medication-assisted treatment for various issues and explore currently available medications. Practice and policy examples addressing the use of MAT in child welfare and dependency court jurisdictions will be presented and discussed.
  
  Presenter(s):
  - - Nancy K. Young, PhD
    - Mark W. Parrino, MPA
  Date: July 7, 2011
  Watch Video Medication-Assisted Treatment (MAT) Series, Part I of II: Understanding MAT for Families Affected by Substance Use Disorders
- Medication-Assisted Treatment (MAT) Series, Part II of II: Medication-Assisted Treatment During Pregnancy, Post-natal and Beyond
  The second of this two-part series will focus on the needs of pregnant women seeking medication-assisted treatment and discuss other issues in the post-natal phase and beyond.
  
  Presenter(s):
  - - Cathleen Otero, MSW, MPA
    - Karol Kaltenback, PhD
  Date: August 4, 2011
  Watch Video Medication-Assisted Treatment (MAT) Series, Part II of II: Medication-Assisted Treatment During Pregnancy, Post-natal and Beyond
Screening and Assessment for Family Engagement and Retention
- Screening and Assessment for Family Engagement and Retention
  This webinar presents information on screening and assessment for family engagement and retention. Screening, assessment as well as communication and active collaboration across systems help ensure that parents in need of substance abuse treatment are identified and receive appropriate treatment in a timely manner. This webinar will explore strategies and issues involved at both a systems and practice level. Specifically, participants will learn about Connecticut’s Recovery Specialist Voluntary Program (RSVP). RSVP is a program for child welfare involved parents/caregivers who have had a child removed that facilitates timely access to family-centered substance use treatment. This program is a result of a joint collaboration between child welfare, the dependency courts and substance use treatment to develop an integrated system of care for substance affected families by changing policies, procedures and practices to promote inter-agency collaboration and data sharing. A panel will highlight the creative solutions that the collaborative used to sustain and expand beyond the original pilot sites by engaging key stakeholders and re-directing funding.
  
  Presenter(s):
  - - Nancy K. Young, PhD
    - Sara J. Becker, PhD
    - Linda Carpenter
  Date: December 9, 2014
  Watch Video Screening and Assessment for Family Engagement and Retention
Trauma
- Trauma-Informed Care for Families Affected by Substance Use Disorders
  This webinar will explore the systems and practice level changes that can be made to provide trauma-informed care. Participants will learn about NCSACW’s Trauma-Informed Care Assessment Project, through which NCSACW and Dr. Vivian Brown conducted trauma-informed care walkthrough assessments with five partnerships across the country with Family Drug Courts that serve families affected by substance abuse and child maltreatment. These walkthrough assessments enabled the sites to better understand services through the eyes of their clients, uncovered inadvertent trauma triggers and generated concrete changes to become a more trauma-informed system. Participants of this webinar will learn key strategies they can implement at their agency to minimize trauma triggers for clients. Dr. Laurie Markoff will describe the core competencies of trauma-informed interactions and participants will hear case vignettes that highlight use of these competencies. Participants will learn key skills that helping professionals can use to better engage clients who have been affected by trauma.
  
  Presenter(s):
  - - Melissa Lujan, MA
    - Sara J. Becker, PhD
    - Dr. Vivian Brown
    - Amanda Kellerman, MSW
    - Dr. Laurie S. Markoff
  Date: March 26, 2015
  Watch Video Trauma-Informed Care for Families Affected by Substance Use Disorders
Models of Collaboration
- Regional Partnership Grant – Enhanced Collaboration, Promising Results
  In this webinar, the Children’s Bureau in the Administration on Children, Youth, and Families, with the National Center on Substance Abuse and Child Welfare present findings from the Regional Partnership Grant program. On September 28, 2006, the Child and Family Services Improvement Act of 2006 (P.L. 109-288) was signed into law. The legislation was designed to improve the lives of abused and neglected children and their families, and included provisions that specifically address those children who are affected by a parent’s methamphetamine and other substance use disorders. In 2007, the Children’s Bureau awarded 53 grantees representing state, county, and tribal partnerships “Targeted Grants to Increase the Well-Being of, and to Improve the Permanency Outcomes for, Children Affected by Methamphetamine or Other Substance Abuse.” The RPG Program represents the largest data set ever collected on families with substance use disorders in or at risk of entering the child welfare system. The webinar will highlight the strategies and services that were implemented, outcomes achieved, lessons learned in implementation and evaluation, and successful sustainability strategies.
  
  Presenter(s):
  - - Ken DeCerchio, MSW, CAP
    - Chad Rodi, PhD
  Date: April 16, 2014
  Watch Video Regional Partnership Grant – Enhanced Collaboration, Promising Results
- New England Practice and Policy: Kick-off Webinar
  This kick-off webinar provides an overview of the issues facing child welfare, substance abuse treatment providers and the courts in the New England region, presents current models of reform, integrates identified priority areas, and discusses common barriers and contextual issues for New England.
  
  Presenter(s):
  - - Nancy K. Young, PhD
    - Sara J. Becker, PhD
    - Sharon Amatetti, M.P.H
  Date: September 30, 2014
  Watch Video New England Practice and Policy: Kick-off Webinar
Evidence Based Practices for Families Affected by Substance Use Disorders
- The Nurturing Program for Families in Substance Abuse Treatment and Recovery
  This webinar discusses practical issues around the implementation of the Nurturing Program for Families in Substance Abuse Treatment and Recovery. The Nurturing Program for Families in Substance Abuse Treatment and Recovery curriculum was first published in 1995 and was adapted from the Nurturing Program for Parents and Children Birth to 5 Years to address the specific needs of families affected by parental substance abuse. The curriculum focuses on the effects of substance abuse on families, parenting, and the parent-child relationship.
  
  The webinar features Terri Bogage, MSW, LICSW, the Director of Family and Children’s Services and Dianna Christmas, MPH, Parent-Child Services Coordinator at the Institute for Health and Recovery (IHR). The webinar will discuss: implementation considerations and challenges; issues related to adaptation of the model; implementation drivers and challenges; and fidelity monitoring.
  
  Presenter(s):
  - - Dianna Christmas, MPH
    - Terri Bogage, MSW, LICSW Institute for Health and Recovery
    - Ken DeCerchio, MSW, CAP
    - Marianna Corona, MSW
  Date: August 6, 2014
  Watch Video The Nurturing Program for Families in Substance Abuse Treatment and Recovery
- Practical Issues in the Implementation of the Matrix Model
  This webinar discusses practical issues around the implementation of the Matrix Model. The Matrix Model is an intensive outpatient treatment approach for stimulant abuse and dependence that was developed through 20 years of experience in real-world treatment settings. The intervention consists of relapse-prevention groups, education groups, social-support groups, individual counseling, and urine and breath testing delivered over a 16-week period. The program includes education for family members affected by the addiction. The webinar features Jeanne L. Obert, LMFT, MSM. Ms. Obert is a founder, past Executive Director and present Chairperson of the Board of Matrix Institute, a nonprofit corporation that delivers outpatient treatment and mental health services in the Los Angeles, CA area. Matrix is affiliated with the UCLA Integrated Substance Abuse Programs and is a site for the National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN). Recently she worked with others to create the soon-to-be-released second edition of the Hazelden Matrix materials and a Matrix manual for persons involved in the criminal justice system. She has worked to create a system designed to disseminate the Model with fidelity nationally and internationally. The webinar will discuss: implementation considerations and challenges; issues related to adaptation of the model; implementation drivers and challenges; fidelity monitoring, and measurement of impact and outcomes.
  
  Presenter(s):
  - - Jeanne Obert, LMFT, MSM
    - Andrea Weiner
    - Ken DeCerchio
    - Elaine Stedt, MSW
  Date: October 22, 2014
  Watch Video Practical Issues in the Implementation of the Matrix Model
- Developing a Coordinated Response to Families Affected by Substance Use Disorders
  Research and practical experience has long demonstrated the prevalence of parental substance use disorders (SUD) among families in the child welfare system. Historically, a lack of coordination and collaboration has hindered the ability of multiple service providers in supporting families impacted SUDs. As child welfare involved families have complex needs, a coordinated effort between systems is needed. Most recently, the increasing number of jurisdictions that are working to develop a response to families affected by opioid use has cast a renewed interest on the issue. The Children’s Bureau staff has partnered with the National Center on Substance Abuse and Child Welfare (NCSACW) to facilitate a webinar for Children’s Justice Act (CJA) grantees addressing collaborative practice at the "front-end" of child welfare practice (e.g. intake and investigation). The presenters will share lessons learned from collaborative site examples. Participants will also learn about resources available through NCSACW and how to access technical assistance.
  
  Presenter(s):
  - - Hanh Dao, MSW
  Date: May 6, 2015
  Watch Video Developing a Coordinated Response to Families Affected by Substance Use Disorders